DZ2892A1 - Livraison d'agent actif atomisé par modulation résistance de débit. - Google Patents

Livraison d'agent actif atomisé par modulation résistance de débit.

Info

Publication number
DZ2892A1
DZ2892A1 DZ990192A DZ990192A DZ2892A1 DZ 2892 A1 DZ2892 A1 DZ 2892A1 DZ 990192 A DZ990192 A DZ 990192A DZ 990192 A DZ990192 A DZ 990192A DZ 2892 A1 DZ2892 A1 DZ 2892A1
Authority
DZ
Algeria
Prior art keywords
delivery
active agent
flow resistance
resistance modulation
atomized active
Prior art date
Application number
DZ990192A
Other languages
English (en)
French (fr)
Inventor
Andrew Clark
Original Assignee
Inhale Therapeutic Syst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inhale Therapeutic Syst filed Critical Inhale Therapeutic Syst
Application granted granted Critical
Publication of DZ2892A1 publication Critical patent/DZ2892A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Otolaryngology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
DZ990192A 1998-09-14 1999-09-13 Livraison d'agent actif atomisé par modulation résistance de débit. DZ2892A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10016398P 1998-09-14 1998-09-14

Publications (1)

Publication Number Publication Date
DZ2892A1 true DZ2892A1 (fr) 2003-12-15

Family

ID=22278404

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ990192A DZ2892A1 (fr) 1998-09-14 1999-09-13 Livraison d'agent actif atomisé par modulation résistance de débit.

Country Status (44)

Country Link
EP (1) EP1117442A1 (xx)
JP (1) JP2002524535A (xx)
KR (1) KR20010075063A (xx)
CN (1) CN1317977A (xx)
AP (1) AP1374A (xx)
AR (1) AR022090A1 (xx)
AU (1) AU753014B2 (xx)
BG (1) BG105430A (xx)
BR (1) BR9913722A (xx)
CA (1) CA2343920A1 (xx)
CO (1) CO5130023A1 (xx)
CZ (1) CZ2001829A3 (xx)
DZ (1) DZ2892A1 (xx)
EA (1) EA003476B1 (xx)
EE (1) EE200100151A (xx)
GE (1) GEP20043257B (xx)
GT (1) GT199900156A (xx)
HK (1) HK1042231A1 (xx)
HN (1) HN1999000159A (xx)
HR (1) HRP20010189A2 (xx)
HU (1) HUP0103837A3 (xx)
ID (1) ID28845A (xx)
IL (2) IL141562A0 (xx)
IS (1) IS5878A (xx)
LT (1) LT4897B (xx)
LV (1) LV12658B (xx)
MA (1) MA25590A1 (xx)
MY (1) MY129282A (xx)
NO (1) NO20011251L (xx)
NZ (1) NZ510168A (xx)
OA (1) OA11781A (xx)
PA (1) PA8481901A1 (xx)
PE (1) PE20001061A1 (xx)
PL (1) PL195574B1 (xx)
SA (1) SA99200718B1 (xx)
SK (1) SK3442001A3 (xx)
TN (1) TNSN99173A1 (xx)
TR (1) TR200101182T2 (xx)
TW (1) TWI226248B (xx)
UA (1) UA76085C2 (xx)
UY (1) UY25711A1 (xx)
WO (1) WO2000015262A1 (xx)
YU (1) YU24201A (xx)
ZA (1) ZA200101995B (xx)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6630121B1 (en) 1999-06-09 2003-10-07 The Regents Of The University Of Colorado Supercritical fluid-assisted nebulization and bubble drying
US6475468B2 (en) * 2001-02-15 2002-11-05 Aeropharm Technology Incorporated Modulated release particles for aerosol delivery
EP1392262A1 (en) * 2001-05-24 2004-03-03 Alexza Molecular Delivery Corporation Delivery of drug esters through an inhalation route
EG24184A (en) 2001-06-15 2008-10-08 Otsuka Pharma Co Ltd Dry powder inhalation system for transpulmonary
US7759506B2 (en) 2002-02-25 2010-07-20 Diffusion Pharmaceuticals Llc Bipolar trans carotenoid salts and their uses
US7351844B2 (en) 2002-02-25 2008-04-01 Diffusion Pharmaceuticals Llc Bipolar trans carotenoid salts and their uses
AU2003232081B2 (en) * 2002-07-03 2009-02-05 Brandeis University Central airway administration for systemic delivery of therapeutics
ES2280835T3 (es) * 2002-12-19 2007-09-16 Pharmacia Corporation Formulacion no higroscopica que comprende un farmaco higroscopico.
DE10338403A1 (de) * 2003-08-18 2005-03-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pulverformulierung, enthaltend den CGRP-Antagonisten 1-[N2-[3,5-Dibrom-N-[[4-(3,4-dihydro-2(1H)-oxochinazolin-3-yl]-1-piperidinyl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyrindinyl)-piperazin, Verfahren zu dessen Herstellung sowie dessen Verwendung als Inhalativum
GB0327723D0 (en) * 2003-09-15 2003-12-31 Vectura Ltd Pharmaceutical compositions
US20070020299A1 (en) 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
JP2007534693A (ja) 2004-04-23 2007-11-29 サイデックス・インコーポレイテッド スルホアルキルエーテルシクロデキストリンを含有するｄｐｉ製剤
JP2008531582A (ja) 2005-02-24 2008-08-14 ディフュージョン・ファーマシューティカルズ・エルエルシー トランスカロテノイド、それらの合成、配合、および使用
RU2007137121A (ru) * 2005-03-09 2009-04-20 Оно Фармасьютикал Ко., Лтд. (Jp) Частица и препарат, содержащий указанную частицу
HUE035181T2 (hu) 2005-10-26 2018-05-02 Cydex Pharmaceuticals Inc Szulfoalkil-éter-ciklodextrin kompozíciók és eljárások elõállításukra
US7629331B2 (en) 2005-10-26 2009-12-08 Cydex Pharmaceuticals, Inc. Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
US20080035143A1 (en) * 2006-08-14 2008-02-14 Sievers Robert E Human-powered dry powder inhaler and dry powder inhaler compositions
KR20090081407A (ko) * 2006-10-25 2009-07-28 다이닛본 스미토모 세이야꾸 가부시끼가이샤 고결 방지 과립상 제제
EP1925295A1 (de) * 2006-11-22 2008-05-28 Boehringer Ingelheim Pharma GmbH & Co. KG Stabile Pulverformulierung enthaltend ein Anticholinergikum
EA200970944A1 (ru) 2007-04-13 2010-06-30 Диффьюжн Фармасьютикалз Ллс Применение биполярных транскаротиноидов в качестве предварительного лечения при лечении заболевания периферических сосудов
MX2010004803A (es) 2007-10-31 2010-09-09 Diffusion Pharmaceuticals Llc Una nueva clase de composiciones terapeuticas que mejoran la difusion de moleculas pequeñas.
TR201802619T4 (tr) * 2009-05-20 2018-03-21 Aeras Kararlı, sprey ile kurutulmuş, immunojen, viral bileşimler.
CA2765697C (en) 2009-06-22 2019-11-12 Diffusion Pharmaceuticals Llc Diffusion enhancing compounds and their use alone or with thrombolytics
EP2575487B1 (en) 2010-06-02 2017-10-18 Diffusion Pharmaceuticals Llc Oral formulations of bipolar trans carotenoids
IN2014MN02359A (xx) 2012-05-03 2015-08-14 Janssen R & D Ireland
BR112015010601B1 (pt) * 2012-11-09 2022-07-19 Civitas Therapeutics, Inc. Composição farmacêutica e uso da composição
WO2015042352A1 (en) * 2013-09-20 2015-03-26 Virginia Commonwealth University Delivery of particles using hygroscopic excipients
CA2965759C (en) 2014-10-31 2023-12-12 Glaxosmithkline Intellectual Property Development Limited Powdered polypeptides with decreased disulfide impurities comprising divalent cationic materials
KR20230014850A (ko) 2016-03-24 2023-01-30 디퓨젼 파마슈티컬즈 엘엘씨 암을 치료하기 위한, 화학 요법 및 방사선 요법과의 양극성 트랜스 카로티노이드의 용도

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3155573A (en) * 1958-05-06 1964-11-03 Benger Lab Ltd Inhalant composition and method of making same
CA2115065C (en) * 1992-06-12 2000-10-03 Kiyoyuki Sakon Ultrafine particle powder for inhalation and method for production thereof
US6524557B1 (en) * 1994-12-22 2003-02-25 Astrazeneca Ab Aerosol formulations of peptides and proteins
US5874064A (en) 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
CA2277801C (en) * 1997-01-16 2002-10-15 Massachusetts Institute Of Technology Preparation of particles for inhalation
US6086376A (en) * 1998-01-30 2000-07-11 Rtp Pharma Inc. Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant

Also Published As

Publication number Publication date
HUP0103837A2 (hu) 2002-05-29
PL195574B1 (pl) 2007-10-31
CN1317977A (zh) 2001-10-17
ZA200101995B (en) 2002-03-11
NO20011251D0 (no) 2001-03-13
TWI226248B (en) 2005-01-11
LT2001021A (en) 2001-11-26
NZ510168A (en) 2003-09-26
CO5130023A1 (es) 2002-02-27
ID28845A (id) 2001-07-05
IL141562A (en) 2007-07-24
AU753014B2 (en) 2002-10-03
SA99200718B1 (ar) 2006-11-04
CZ2001829A3 (cs) 2001-09-12
HK1042231A1 (zh) 2002-08-09
PE20001061A1 (es) 2000-10-08
JP2002524535A (ja) 2002-08-06
HRP20010189A2 (en) 2005-04-30
EP1117442A1 (en) 2001-07-25
IS5878A (is) 2001-03-05
CA2343920A1 (en) 2000-03-23
AP1374A (en) 2005-02-28
AR022090A1 (es) 2002-09-04
PA8481901A1 (es) 2002-04-25
MY129282A (en) 2007-03-30
EA200100300A1 (ru) 2001-10-22
GEP20043257B (en) 2004-06-25
KR20010075063A (ko) 2001-08-09
HUP0103837A3 (en) 2002-11-28
OA11781A (en) 2005-07-26
AP2001002093A0 (en) 2001-03-31
AU6039799A (en) 2000-04-03
YU24201A (sh) 2003-08-29
EE200100151A (et) 2002-06-17
HN1999000159A (es) 1999-11-11
BR9913722A (pt) 2001-05-29
UY25711A1 (es) 1999-11-17
LV12658A (lv) 2001-05-20
SK3442001A3 (en) 2001-11-06
PL346768A1 (en) 2002-02-25
MA25590A1 (fr) 2002-12-31
TR200101182T2 (tr) 2001-09-21
LV12658B (lv) 2001-09-20
GT199900156A (es) 2001-03-07
TNSN99173A1 (fr) 2005-11-10
IL141562A0 (en) 2002-03-10
NO20011251L (no) 2001-04-17
EA003476B1 (ru) 2003-06-26
WO2000015262A1 (en) 2000-03-23
BG105430A (en) 2001-12-29
LT4897B (lt) 2002-02-25
UA76085C2 (en) 2006-07-17

Similar Documents

Publication Publication Date Title
DZ2906A1 (fr) Livraison d'agent actif atomisé par modulation résistance de débit.
DZ2892A1 (fr) Livraison d'agent actif atomisé par modulation résistance de débit.
ES2155124T3 (es) Composiciones farmaceuticas liquidas a base de hormonas tiroideas.
ID22349A (id) Turunan dari 8-azabisiklo [3.2.1] oktana-, 8-azabisiklo [3.2.1] okt-6-ena-, 9-azabisiklo-[3.3.1] nonana-, 9-aza-3-oksabisiklo [3.3.1] nonana- dan 9-aza-3-tiobisiklo [3.3.1] nonana, pembuatannya dan penggunaannya sebagai insektisida
LT2000095A (en) Aerosolised active agent delivery
BR9804500B1 (pt) derivado de amida, referida composição farmacêutica e agente terapêutico.
IL208330A0 (en) 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors ('statin drugs') and lisinopril, formulations comprising them and their use in the manufacture of medicaments and as medicaments for improving nerve conduction velocity or nerve blood flow in a non-human animal having diabetic neuropathy and for treating diabetic neuropathy in a non-human animal
ATE242249T1 (de) Herbizid aktive 3-hydroxy-4-aryl-5- oxopyrazolinderivate
ITMI981774A0 (it) Composizioni farmaceutiche ad attivita' analgesica
DE69713557D1 (de) Wässrige flüssige landwirtschaftliche zusammensetzung
DE69821977D1 (de) Flüssige, insektizide aufgiessformulierung
BR9913699A (pt) Composição inseticida
ITMI20001848A0 (it) Faramaci per l'incontinenza.
HK1035641A1 (en) Bacteriocide compositions for agricultural and horticultural use.
IT1307264B1 (it) Composizioni insetticide.
AU1389702A (en) Optically active 2,5-bisaryl-delta<sup>1</sup>-pyrrolines and their use as pest control agents
DE69504824D1 (de) Substituierte 5,6- dihydro-5-oxo-1,4 -dithiino-(2,3-d) pyridazin-dicarbonitrile, diese enthaltende zusammensetzungen und ihre verwendung als antimikrobielle mittel
IT1314209B1 (it) Composizione fertilizzante particolarmente idonea per l'agricolturabiologica
IT1312355B1 (it) Composti pirrolici aventi elevata attivita' erbicida e loro utilizzoagronomico
FR2782243B1 (fr) Preparation d'une composition phytosanitaire solide par atomisation en presence d'un agent anti-mousse
ES1042364Y (es) "pañal perfeccionado".
DE59904440D1 (de) Gezogene Landwirtschaftliche Feldspritze
UA43435C2 (uk) Композиція інгредієнтів для гіркої настоянки "старовинна"
IT1298987B1 (it) Composizioni terapeutiche ad attivita' antivirale comprendenti yohimbina e/o suoi sali come principio attivo
ZA99866B (en) 2-(pyrazolyloxy)pyridin-3-ylacetic acid derivatives, compositions comprising them and their use for controlling harmful fungi and animal pests.